In August 2021 Finfeed changed from a website that covered ASX listed news to a website
that covered a select range of ASX
listed small cap Biotech stocks that we are personally invested in: find out more.
The old Finfeed website, and all of the old articles are kept here for record keeping purposes.VISIT NEW SITE
Invigor’s Condat set to deliver strongest ever result for FY2017
2 minute read
The business is currently on target to deliver its strongest ever financial result in FY2017.
The forward outlook also appears promising based on its workbook at the beginning of October.
The group had booked orders combined with contracts being finalised with a value of more than $2.7 million; these comprised new contracts and contract extensions for customers across Europe.
Revenue of $7.6 million is forecast in FY2017, up from $7 million in the previous financial year. A large percentage of the anticipated full year income flows from recurring revenue-generating contracts that have high retention rates and scope for renewal at increased values given the potential to provide add-on services.
However, this is an early stage play and as such any investment decision should be made with caution and professional financial advice should be sought.
Condat’s significant proportion of annualised revenues should be viewed favourably by investors as it provides earnings predictability.
Margins strengthen to deliver EBITDA in excess of $1 million
Condat’s margins have increased significantly and the group is forecast to deliver a 115 per cent increase in EBITDA to circa $1.1 million, up from $512,000 in FY2016.
Management noted that the strong financial performance reflects Condat’s prominent position as an established industry player and leading vendor of IT-based smart media solutions, together with the increased deployment of its Skyware Workforce Management software solution.
Customers include broadcasters, media companies, content distributors and infrastructure operators across Europe.
Commenting on the division’s performance, IVO’s Chief Executive Gary Cohen said, “Condat continues to deliver very strong growth as part of Invigor, which is clearly evident by the forecast EBITDA performance for this financial year, greatly improved earnings margins, solid revenue growth, and the strengthening sales pipeline”.
There is also scope to accelerate growth and on that note Cohen said that the company was assessing ways to capitalise on Condat’s well-established European presence. He also noted that there was the likelihood of new contract wins and extensions from the group’s operations in Australia and Asia which should be formalised in the near term.
Based on the forecast revenue and EBITDA numbers it would appear that the Condat business is generating margins of circa 15 per cent. Based on the collective value of new orders booked and pending contract awards of $2.7 million this would equate to EBITDA of approximately $400,000.